federal_register: 2012-24475

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2012-24475 New Animal Drugs; Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin Rule The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) during August 2012 and to reflect a change of sponsor's address for Baxter Healthcare Corp. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. 2012-10-04 2012 10 https://www.federalregister.gov/documents/2012/10/04/2012-24475/new-animal-drugs-change-of-sponsors-address-monensin-spinosad-tilmicosin https://www.govinfo.gov/content/pkg/FR-2012-10-04/pdf/2012-24475.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) during August 2012 and to reflect a change of sponsor's address for Baxter Healthcare Corp. FDA is also...

Links from other tables